Challenges and progress in the development of a serogroup B meningococcal vaccine. - Wikidata - awgldk - TriplyDB

Challenges and progress in the development of a serogroup B meningococcal vaccine.

Challenges and progress in the development of a serogroup B meningococcal vaccine.

http://www.wikidata.org/entity/Q37503243

about

Structure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidis Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.Bioanalysis of meningococcal vaccines.A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.Recent progress towards development of a Shigella vaccine.Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.Prevalence and genetic diversity of two adhesion-related genes, pilE and nadA, in Neisseria meningitidis in China.

P2860

Q27674699-190FFC36-AA7E-4E25-B8DC-E21E8E19367F Q33704817-FC3F1AE9-AB5F-4DBE-9213-C4375A4E756B Q34529441-2E99E27F-F0EE-461B-B38A-C00B44FEB265 Q34783257-7246DC84-482B-43DC-B281-F21EE22B82A6 Q35191862-E5F8A109-DDC3-459B-AB01-3CB7505C867C Q37514748-B484107E-4E0B-4477-850D-1EAD4C49D6CA Q37810253-2D72D105-7920-46F2-B632-DC26E45F6644 Q37878478-5FCE990E-F75F-4A6D-B0FA-40274D507B76 Q38068954-CF7FD34B-0019-4A4A-A880-34CB484C7347 Q42266218-04EC0A49-778A-4AB9-825C-6A936A65BBEE Q42280033-F9668302-0145-4939-A839-36B98A7F8ED8

P2860

Challenges and progress in the development of a serogroup B meningococcal vaccine.

http://www.wikidata.org/entity/Q37503243

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Challenges and progress in the development of a serogroup B meningococcal vaccine.

@en

Challenges and progress in the development of a serogroup B meningococcal vaccine.

@nl

type

label

Challenges and progress in the development of a serogroup B meningococcal vaccine.

@en

Challenges and progress in the development of a serogroup B meningococcal vaccine.

@nl

prefLabel

Challenges and progress in the development of a serogroup B meningococcal vaccine.

@en

Challenges and progress in the development of a serogroup B meningococcal vaccine.

@nl

P1433

Q37503243-236A79B8-9D5E-4C02-B103-7BB627785B49

P1476

Q37503243-A3168750-3015-49AB-B06F-872F6E9E9E28

P2093

Q37503243-16BBD401-0761-410D-8093-31874E953FF3

Q37503243-2D889055-7566-451E-B031-5484FFB85E34

Q37503243-98FDD268-7EFE-417A-B053-FE9472418D42

P2860

Q37503243-03D7CC09-4793-4CF3-B959-CB29399203B9

Q37503243-08C32D41-8D64-4CFF-A719-55982C9C37CE

Q37503243-0CD5C48C-6BCB-4F01-B775-1A402D59508A

Q37503243-11543D76-4E26-4755-9835-3985BF5C8341

Q37503243-11CE09B8-759F-4A1B-A2D6-0846890E2100

Q37503243-13AFE02B-1421-41D5-AA76-776C8C5B7D2E

Q37503243-1768E616-8768-4EDF-B6BE-B36286D3ADED

Q37503243-18BE4CA1-EBE2-4B51-A548-78FE4593D152

Q37503243-1DA6A476-A29A-48C9-9D95-A66EC704F087

Q37503243-1EA9F832-BD1E-4EF5-BF0A-D8FBADFDC2BC

P304

Q37503243-DD3F48F6-BC32-44FA-B806-83C415936348

P31

Q37503243-3E7027BE-6EB4-4AAB-AE38-EF3BE7BA2FC1

P356

Q37503243-D543B577-7BB8-4176-BADB-BF485BF8DD85

P433

Q37503243-4B085F0E-D87F-4394-9888-705F41A0383B

P478

Q37503243-16C2A05B-5D9F-4A47-AB22-FD58F2E53611

P50

Q37503243-2E2301BB-374C-4C6D-AE20-0961F4832675

P577

Q37503243-A08C008E-686E-483A-9240-B03F70BEBF7A

P698

Q37503243-2C3904AF-BCCF-4897-9CF1-B02E887B8995

P356

P1433

Expert Review of Vaccines

P1476

Challenges and progress in the development of a serogroup B meningococcal vaccine.

@en

P2093

Andrew J Pollard

http://www.w3.org/2001/XMLSchema#string

J Claire Hoe

http://www.w3.org/2001/XMLSchema#string

Susan Lewis

http://www.w3.org/2001/XMLSchema#string

P2860

NadA, a novel vaccine candidate of Neisseria meningitidis

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

Reverse vaccinology, a genome-based approach to vaccine development.

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.

Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model.

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.

Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.

P304

729-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.09.30

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Manish Sadarangani

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19485754

http://www.w3.org/2001/XMLSchema#string